Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexander, D. S.
Right arrow Articles by Quigley, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexander, D. S.
Right arrow Articles by Quigley, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 13, 7457-7461, March 27, 1998

Autoactivation of Avian Urokinase-type Plasminogen Activator (uPA)
A NOVEL MODE OF INITIATION OF THE uPA/PLASMIN CASCADE

Daniela S. Alexander, John D. Sipley, and James P. Quigley

From the Department of Pathology, State University of New York, Stony Brook, New York 11794-8651

In contrast to mammalian urokinase-type plasminogen activator (uPA), which is produced and maintained in zymogen form, avian uPA is found in the active two-chain form in cultures of normal and transformed chicken cells in the absence of plasmin, the putative natural activator of pro-uPA. Recombinant chicken uPA (ch-uPAwt) synthesized in two distinct expression systems also presents in the active two-chain form. In addition, conversion to the active uPA in both natural and recombinant expression systems could be prevented by uPA-specific inhibitors including a monoclonal antibody that uniquely inhibits the catalytic activity of ch-uPA. Most significantly, an active site mutant of avian uPA (ch-uPAS353A) that lacks catalytic activity is produced and maintained in single-chain form. Furthermore, the single-chain ch-uPAS353A mutant can be converted to the two-chain form by purified active ch-uPAwt. These results strongly indicate an autocatalytic mechanism of activation of ch-uPA. Autoactivation appears to be an intrinsic property of ch-uPA and may be the initiating molecular event in uPA-mediated proteolytic cascades.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
H. Rubin
Complementary approaches to understanding the role of proteases and their natural inhibitors in neoplastic development: retrospect and prospect
Carcinogenesis, May 1, 2003; 24(5): 803 - 816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E.-G. Cho, M. G. Kim, C. Kim, S.-R. Kim, I. S. Seong, C. Chung, R. H. Schwartz, and D. Park
N-terminal Processing Is Essential for Release of Epithin, a Mouse Type II Membrane Serine Protease
J. Biol. Chem., November 21, 2001; 276(48): 44581 - 44589.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement